Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report

DOI: 10.2147/OTT.S180845

Keywords: mCRC, BRAFV600E mutation, fluorouracil, vemurafenib, irinotecan, cetuximab

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text